Publication | Closed Access

Ag85B–ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection

Pulmonary TuberculosisTuberculosis PreventionImmunologyPrevious Bcg VaccinationTuberculosisT Cell ImmunityCd4 T Cell ResponsesCellular Immune ResponseImmunotherapyMedicineTuberculosis Infection